Opinions

Pages

Displaying 1 - 10 of 2884
Ongoing (updated on 26/09/2023)
Reference: 
REX/580-EESC

Practical information

  1. Composition of the Study Group
  2. Administrator / Assistant in charge: Sveto TRAJKOVSKI / Elisabete DIAS

Background

The EU-UK Follow-up Committee (Committee) was set up in March 2021 for the purpose of maintaining and strengthening relations between EU and UK civil society organisations, as well as for pursuing any activities contributing to enhancing the relationship between the EU and the UK.

Ongoing (updated on 25/09/2023)
Reference: 
INT/1043-EESC-2023-03693-00-00-AC-TRA

The future Belgian presidency of the Council of the European Union asked the EESC to provide their insights on the rethinking of the internal market in light of the acceleration of the Union’s twin transitions towards a green and digital economy and on crafting a European Industrial Strategy that positions industries as the backbone of Europe's economy.

Ongoing (updated on 25/09/2023)
Reference: 
ECO/626-EESC
Plenary session: 
582 -
Oct 25, 2023 Oct 26, 2023

As committed during the negotiations on the long-term EU budget 2021-2027, the European Commission has on 20 June 2023 completed its proposal for a next generation of own resources. The package includes a new temporary statistical own resource based on company profits. The Commission  also proposes to adjust the own resources proposals based on the Emissions Trading System (ETS) and Carbon Border Adjustment Mechanism (CBAM) compared to the original proposals from December 2021.  

Ongoing (updated on 25/09/2023)
Reference: 
CCMI/212-EESC
Plenary session: 
583 -
Dec 13, 2023 Dec 14, 2023

The Covid 19-pandemic has drawn attention to the role of the pharmaceutical industry and to production, availability and affordability of medicines and medicinal products on the European market.

Dependency on critical ingredients, such as active pharmaceutical ingredients (APIs), became obvious when China and India limited exports. According to current data, up to 80% of APIs used in Europe and about 40% of finished medicines sold in Europe come from China or India. The European Union's increasing dependence on API supplies has led to a partial loss of capability to manufacture active substances independently, which poses a potential threat to public health in the countries of the European Union.

Ongoing (updated on 22/09/2023)
Reference: 
INT/1023-EESC-2023-01711

Corruption and the lack of rule of law undermine the mutual trust that is underpinning the internal market. This opinion should contribute to bringing attention to how challenges to the rule of law affect the internal market and in particular public procurement.

Ongoing (updated on 22/09/2023)
Reference: 
INT/1041-EESC-EESC-2023-03705-00-00-AC-TRA

EU rules on late payments have triggered a reduction in payment delays. However, still more than 60% of businesses in the EU are not paid on time and small and medium-sized enterprises are most affected. The initiative will provide relief to SMEs by revising existing EU payment rules based on available and upcoming evidence to promote a definitive shift towards a culture of “prompt payment".

Pages